[Therapeutic failure of ampicillin during meningococcal meningitis].
Leblanc
A
A
Domalain
M N
MN
Jundt
S
S
Gallet
J P
JP
D000367:Age Factors; D000667:Ampicillin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000737:chemistry / Q000166:cytology / Q000382:microbiology; D002675:Child, Preschool; D016903:Drug Monitoring; D005947:Glucose / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008578:Meninges / Q000187:drug effects; D008585:Meningitis, Meningococcal / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D018579:Patient Selection; D010400:Penicillin G / Q000627:therapeutic use; D011506:Proteins / Q000032:analysis / Q000187:drug effects; D014018:Tissue Distribution; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D011506:Proteins; D000667:Ampicillin; D005947:Glucose; D010400:Penicillin G